Ziopharm Oncology IN (ZIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZIOP | BMY | MRNA | AMGN | GILD |
| Company | Ziopharm Oncology IN | Bristol-Myers Squibb Company | Moderna Inc | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.8900 | 44.77 | 106.70 | 266.15 | 65.66 |
| High | 0.9700 | 44.77 | 106.70 | 266.15 | 65.66 |
| Low | 0.8611 | 44.77 | 106.70 | 266.15 | 65.66 |
| Last | 0.8657 | 44.77 | 106.70 | 266.15 | 65.66 |
| Change | -0.0077 | +0.07 | +0.52 | -3.23 | +0.39 |
| % Change | -0.88% | +0.16% | +0.49% | -1.20% | +0.60% |
| Volume | 2,127,500 | 43,900 | 9,465 | 3,200 | 16,297 |
| 20-Day Average Volume | 2,061,125 | 12,143,096 | 2,940,692 | 2,035,255 | 6,444,024 |
| Previous Close | 0.8734 | 44.70 | 106.18 | 269.38 | 65.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9716 | 49.47 | 105.00 | 269.79 | 68.30 |
| 20-Day Raw Stochastic | 21.70% | 4.56% | 50.56% | 23.55% | 7.01% |
| 20-Day Relative Strength | 38.47% | 28.98% | 53.45% | 42.04% | 30.60% |
| Weighted Alpha | -81.84 | -34.50 | -11.01 | +7.31 | -23.09 |
| Today's Opinion | 100% Sell | 88% Sell | 100% Buy | 72% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 88% Sell | 100% Buy | 72% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 8% Buy | 72% Buy | 40% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.39% since 01/19/22 | -8.40% since 04/19/24 | +5.07% since 04/19/24 | -1.03% since 04/19/24 | -1.65% since 04/19/24 |
| Low | 0.7703 on 01/24/22 | 44.37 on 04/25/24 | 99.30 on 04/22/24 | 266.15 on 04/26/24 | 65.09 on 04/25/24 |
| High | 0.9700 on 01/26/22 | 49.56 on 04/22/24 | 111.29 on 04/24/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 |
| 1-Month | |||||
| %Chg | -31.29% since 12/23/21 | -14.71% since 03/26/24 | -0.80% since 03/26/24 | -5.54% since 03/26/24 | -9.32% since 03/26/24 |
| Low | 0.7703 on 01/24/22 | 44.37 on 04/25/24 | 97.00 on 04/03/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 |
| High | 1.2500 on 12/27/21 | 54.47 on 03/28/24 | 115.89 on 04/09/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -41.51% since 10/26/21 | -9.82% since 01/26/24 | +4.66% since 01/26/24 | -14.63% since 01/26/24 | -17.43% since 01/26/24 |
| Low | 0.7703 on 01/24/22 | 44.37 on 04/25/24 | 84.06 on 02/13/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 |
| High | 1.6800 on 11/05/21 | 55.03 on 03/13/24 | 115.89 on 04/09/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 |
| 6-Month | |||||
| %Chg | -61.18% since 07/26/21 | -15.39% since 10/26/23 | +40.23% since 10/26/23 | -1.32% since 10/26/23 | -16.36% since 10/26/23 |
| Low | 0.7703 on 01/24/22 | 44.37 on 04/25/24 | 62.55 on 11/02/23 | 249.70 on 10/31/23 | 65.09 on 04/25/24 |
| High | 2.4300 on 09/07/21 | 55.03 on 03/13/24 | 115.97 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 187,118 | 90,596,128 | 40,654,200 | 144,488,960 | 81,266,176 |
| Shares Outstanding, K | 216,146 | 2,026,759 | 382,880 | 536,376 | 1,245,077 |
| Annual Sales | 0 | 45,006,000,000 | 6,848,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -79,980,000 | 8,025,000,000 | -4,714,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 400,000 | 11,477,000,000 | 2,811,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -22,730,000 | 1,762,000,000 | 217,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.71 | 0.39 | 1.62 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 05/06/21 | -4.40 on 04/25/24 | 0.55 on 02/22/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 02/24/22 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | N/A | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 0.00 | 14.64 | 9.98 |